rusfertide
protagonist therapeutics
['#mpn', 'rusfertide', 'mpnsm']
congress #asco22 | ronald hoffman discusses rusfertide in pts with pcv in 2 phase ii trials.on rusfertide, pts consistently maintained hct &lt;45%, with 84% not requiring therapeutic phlebotomy during the first 28 weeks of treatment on the revive study. #mpnsm #mpn 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm